Janssen Biotech (Johnson & Johnson)
Erleada is a prescription medicine from Janssen Biotech that is used to treat prostate cancer.
The pharmaceutical agent treats cancer that has spread to other parts of the body but still responds to a medical or surgical treatment that lowers testosterone.
Erleada’s most common side effects include feeling very tired, joint pain, rash, decreased appetite, falling, Weight loss, hypertension, hot flashes, diarrhea and fracture. Janssen Biotech also said the medication may cause fertility problems in males.
Filed Under: Drug Discovery, Drug Discovery and Development, Neurological Disease, Oncology, Orphan Drugs